Atlas Trials

Integro Theranostics

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Integro Theranostics

RecordFirmDate
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer (NCT07276789)Integro Theranostics2025-12-08
A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer (NCT06713564)Integro Theranostics2024-11-07
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer (NCT05900986)Integro Theranostics2023-07-14

Track Integro Theranostics automatically

Every clearance here is in the API, with alerts when new ones post.